Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-678-2 | CAS number: 5932-68-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 18 to July 19, 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Basic data given. Positive control group not included, number of micronucleated immature erythrocytes for each animal not reported.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
- Principles of method if other than guideline:
- According to methodology of MacGregor et al. (1990).
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- (E)-2-methoxy-4-(prop-1-enyl)phenol
- EC Number:
- 227-678-2
- EC Name:
- (E)-2-methoxy-4-(prop-1-enyl)phenol
- Cas Number:
- 5932-68-3
- Molecular formula:
- C10H12O2
- IUPAC Name:
- 2-methoxy-4-prop-1-en-1-ylphenol
- Test material form:
- liquid
- Details on test material:
- - Physical state: Yellow liquid
- Stability under test conditions: Stable
- Storage condition of test material: Stored at or below - 20° C, protected from light, in 1-L Teflon® bottles.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms, Inc., Germantown, NY
- Age at study initiation: 6-7 weeks
- Assigned to test groups randomly: Yes; animals were distributed randomly into groups of approximately equal initial mean body weights.
- Housing: Male animals were housed individually and females were housed 5/cage in polycarbonate cages.
- Diet: NTP-2000 irradiated wafer or pelleted diet (Zeigler Brothers, Inc., Gardners, PA), ad libitum
- Water: Tap water (Columbus, OH, municipal supply) via automatic watering system (Edstrom Industries, Waterford, WI), ad libitum
- Acclimation period: Females: 13 days; males: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature: 72 ± 3 °F
- Humidity: 50 ± 15 %
- Air changes: ≥ 10/h
- Photoperiod: 12 h dark/12 h light
IN-LIFE DATES:
From: April 18, 2001 To: July 19, 2001
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: Corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The appropriate amounts of test material and corn oil were placed in a glass mixing container, capped, and thoroughly mixed with a paint shaker for approximately 5 minutes. Dose formulations were prepared approximately monthly during the study.
ANALYSIS OF FORMULATION:
Test material formulations were analysed three times during the study period. Homogeneity studies of 0.2 and 120 mg/mL formulations and stability studies of the 0.2 mg/mL formulation were performed by the analytical chemistry laboratory using GC. Homogeneity was confirmed, and the 120 mg/mL dose formulation was found to be suitable for gavage. Stability was confirmed for up to 35 days for dose formulations stored in amber glass bottles with Teflon® -lined lids at – 20 °C, 5 °C, and room temperature, as well as for 3 h under simulated animal room conditions. All the formulations analysed were within 10 % of the target concentrations.
DOSE VOLUME: 10 mL/kg bw/day - Duration of treatment / exposure:
- 14 weeks
- Frequency of treatment:
- 5 days/week
- Post exposure period:
- No data
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 37.5 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 75 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 150 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 600 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5 (except vehicle control in females where 8 animals used)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- None
Examinations
- Tissues and cell types examined:
- - Frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each animal per treatment group was determined.
- Percentage of polychromatic erythrocytes (PCEs) in a population of 1000 erythrocytes was determined as a measure of bone marrow toxicity. - Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES:
- At the end of the 3-month toxicity study, peripheral blood samples were obtained from male and female animals.
DETAILS OF SLIDE PREPARATION:
- Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded.
METHOD OF ANALYSIS:
- Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each animal per treatment group.
- Percentage of polychromatic erythrocytes (PCEs) in a population of 1000 erythrocytes was determined as a measure of bone marrow toxicity. - Evaluation criteria:
- - In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups.
- A final call of positive for micronucleus induction is preferably based on reproducibly positive trials.
- Statistical as well as biological factors are considered. - Statistics:
- - The results were tabulated as the mean of the pooled results from all animals within a treatment group plus or minus the standard error of the mean.
- The frequency of micronucleated cells among NCEs was analysed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each dosed group and the control group.
- In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Significance was considered at p≤ 0.025.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- positive
- Remarks:
- female mice
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): The frequencies of micronucleated erythrocytes were not increased in peripheral blood of male animals exposed to 37.5 to 600 mg/kg bw/day of test material by gavage for 3 months; in contrast, a 3.2-fold increase of micronucleated erythrocytes in females at 600 mg/kg bw/day were observed.
Any other information on results incl. tables
Table 7.6.2/1. Micronucleus data
Dose (mg/kg bw/day) |
No. of animals with erythrocytes scored |
Micronucleated NCEs/1000 NCEs (mean ± SE) |
P value* |
PCEs (%) |
0 (corn oil) |
5M |
0.90 ± 0.37 |
|
2.3 |
37.5 |
5M |
1.60 ± 0.46 |
0.0806 |
2.8 |
75 |
5M |
0.70 ± 0.25 |
0.6915 |
3.1 |
150 |
5M |
0.90 ± 0.24 |
0.5000 |
2.8 |
300 |
5M |
0.30 ± 0.12 |
0.9584 |
2.5 |
600 |
5M |
0.90 ± 0.19 |
0.5000 |
2.9 |
|
P = 0.841# |
|
||
0 (corn oil) |
8F |
0.50 ± 0.16 |
|
2.8 |
37.5 |
5F |
1.10 ± 0.19 |
0.0408 |
3.5 |
75 |
5F |
0.20 ± 0.12 |
0.8850 |
3.1 |
150 |
5F |
0.70 ± 0.30 |
0.2568 |
2.7 |
300 |
5F |
1.00 ± 0.35 |
0.0680 |
3.4 |
600 |
5F |
1.60 ± 0.40 |
0.0022 |
2.4 |
|
P = 0.001# |
|
Keys:
NCE = Normochromatic erythrocyte
PCE = Polychromatic erythrocyte
* Pairwise comparison with the vehicle control; dosed group values are significant at P ≤ 0.005.
# Significance of micronucleated NCEs/1000 NCEs tested by the one-tailed trend test; significant at P≤ 0.025
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions, the test material showed a statistically significant increase in the frequency of micronucleated erythrocytes in female mice. This was concluded by the authors to be evidence of a positive response. However, the female vehicle control group had a particularly low mean and standard deviation for the frequency of micronucleated erythrocytes and there was no clear dose response relationship, therefore the response was considered to an artefact. The test material was not considered to be clastogenic or aneugenic in male or female mice.
- Executive summary:
In an in vivo bone marrow micronucleus test, groups of B6C3F1 mice (5/sex/dose) were exposed to test material in corn oil at doses of 37.5, 75, 150, 300 and 600 mg/kg bw/day, 5 days/week for 14 weeks, by gavage. At the end of the study period, peripheral blood samples were obtained from treated animals and smears were prepared immediately. Slides were fixed, stained and coded for analysis. Frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each animal per treatment group was determined. In addition, the percentage of polychromatic erythrocytes (PCEs) in a population of 1000 erythrocytes was determined as a measure of bone marrow toxicity.
No significant changes in the percentage of PCEs were observed over the dose range tested in either males or females, indicating an absence of treatment-related toxicity to the bone marrow. The frequencies of micronucleated erythrocytes were not increased in peripheral blood of male mice at any dose level. In contrast, female mice had a 3.2-fold increase of micronucleated erythrocytes at 600 mg/kg bw/day.
Under the test conditions, the test material showed a statistically significant increase in the frequency of micronucleated erythrocytes in female mice. This was concluded by the authors to be evidence of a positive response. However, the female vehicle control group had a particularly low mean and standard deviation for the frequency of micronucleated erythrocytes and there was no clear dose response relationship, therefore the response was considered to an artefact. The test material was not considered to be clastogenic or aneugenic in male or female mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.